Get the Stockscreener App
5.42
0.91%
-0.05
Meiragtx Holdings Plc stock is traded at $5.42, with a volume of 759.67K.
It is down -0.91% in the last 24 hours and up +0.93% over the past month.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
See More
Previous Close:
$5.47
Open:
$5.75
24h Volume:
759.67K
Relative Volume:
1.24
Market Cap:
$579.65M
Revenue:
$14.02M
Net Income/Loss:
$-84.03M
P/E Ratio:
-3.6871
EPS:
-1.47
Net Cash Flow:
$-125.54M
1W Performance:
-25.24%
1M Performance:
+0.93%
6M Performance:
-21.68%
1Y Performance:
+6.27%
1-Day Range:
$5.3033
$5.80
1-Week Range:
$5.14
$7.30
52-Week Range:
$3.85
$8.75
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Name
Meiragtx Holdings Plc
Sector
Industry
Phone
646-860-7985
Address
450 EAST 29TH STREET, NEW YORK, NY
Compare MGTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
5.42 | 579.65M | 14.02M | -84.03M | -125.54M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Resumed | Chardan Capital Markets | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Sep-03-19 | Initiated | Piper Jaffray | Overweight |
| Feb-27-19 | Reiterated | Chardan Capital Markets | Buy |
| Jul-03-18 | Initiated | Barclays | Overweight |
| Jul-03-18 | Initiated | BofA/Merrill | Buy |
View All
Meiragtx Holdings Plc Stock (MGTX) Latest News
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMA - GuruFocus
MeiraGTx (MGTX) Gains RMAT Designation for Parkinson's Treatment - GuruFocus
FDA grants RMAT status to MeiraGTx’s Parkinson’s treatment By Investing.com - Investing.com South Africa
MeiraGTx (MGTX) Gains FDA RMAT Designation for Parkinson's Treat - GuruFocus
MeiraGTx gets FDA RMAT status for its Parkinson’s disease treatment - Seeking Alpha
MeiraGTx (MGTX) Gains FDA RMAT Designation for Parkinson's Treatment | MGTX Stock News - GuruFocus
MeiraGTx Holdings Receives FDA RMAT Designation for AAV-GAD - TipRanks
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson's Disease - The Manila Times
FDA grants RMAT status to MeiraGTx’s Parkinson’s treatment - Investing.com
MeiraGTx Holdings Receives RMAT Designation from FDA for AAV-GAD Gene Therapy in Parkinson's Disease - Nasdaq
Invesco Ltd. Increases Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings PLC expected to post a loss of 49 cents a shareEarnings Preview - TradingView
MeiraGTx Holdings plc's (NASDAQ:MGTX) Shift From Loss To Profit - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Bought by Geode Capital Management LLC - Defense World
Kadmon Announces Sale of 1.4 Million Shares of MeiraGTx Holdings plc - ACCESS Newswire
What is the investor’s view on MeiraGTx Holdings plc (MGTX)? - uspostnews.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by JPMorgan Chase & Co. - Defense World
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - ADVFN
MeiraGTx CFO Richard Giroux sells $144,000 in stock By Investing.com - Investing.com India
MeiraGTx CFO Richard Giroux sells $144,000 in stock - Investing.com
Parkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Russell Investments Group Ltd. Has $1.72 Million Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MGTX Stock Update: MeiraGTx Holdings plc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Corebridge Financial Inc. - Defense World
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 By Investing.com - Investing.com UK
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 - Investing.com
(MGTX) Trading Advice - news.stocktradersdaily.com
MeiraGTx Holdings Signs New Lease in New York - TipRanks
MeiraGTx Holdings secures new lease, terminates old sublease - Investing.com Australia
MeiraGTx Holdings secures new lease, terminates old sublease By Investing.com - Investing.com Canada
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Debt Sensibly? - simplywall.st
MeiraGTx Reports Strategic Advances and Financial Results - TipRanks
Charles Schwab Investment Management Inc. Buys 12,961 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Chardan Capital Forecasts MeiraGTx FY2026 Earnings - MarketBeat
Chardan Capital Comments on MeiraGTx FY2026 Earnings - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Position Increased by Bank of New York Mellon Corp - Defense World
Chardan Capital Forecasts MeiraGTx FY2025 Earnings - Defense World
MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo
Reviewing MeiraGTx (NASDAQ:MGTX) and CRISPR Therapeutics (NASDAQ:CRSP) - Defense World
MeiraGTx (NASDAQ:MGTX) Given New $13.00 Price Target at Royal Bank of Canada - Defense World
MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment - Insider Monkey
RBC Capital raises MeiraGTx stock price target to $13.00 By Investing.com - Investing.com Canada
RBC Capital raises MeiraGTx stock price target to $13.00 - Investing.com
RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk - MarketScreener
Meiragtx Holdings Plc Stock (MGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):